CHRIS ZOCK

Chris Zock stands as a prominent figure in the venture capital landscape, serving as a Managing Director at Sandbox Industries. In this pivotal role, he is instrumental in identifying, evaluating, and nurturing early-stage companies with disruptive potential, particularly within the dynamic healthcare and digital health sectors. Sandbox Industries is renowned for managing several corporate venture funds, including the BlueCross BlueShield Venture Fund and Healthbox, where Zock's expertise is critical in shaping investment strategies and driving portfolio success.

Zock's investment focus at Sandbox Industries centers on innovative solutions that aim to transform healthcare delivery, patient engagement, and overall wellness. He actively seeks out companies leveraging technology to create more efficient, accessible, and personalized health experiences. His work involves close collaboration with corporate partners, aligning venture investments with strategic industry needs and fostering growth for promising startups. This strategic approach helps portfolio companies not only secure capital but also gain valuable market access and operational guidance.

Prior to his tenure as Managing Director, Chris Zock steadily climbed the ranks at Sandbox Industries, beginning as an Associate and later becoming a Principal. This progression underscores his deep understanding of the firm's investment philosophy and his consistent track record in the venture capital space. Before joining Sandbox Industries, Zock honed his financial acumen as an Investment Banking Analyst at William Blair & Company, a leading global investment bank. This foundational experience provided him with a robust understanding of financial markets, corporate finance, and strategic transactions, which he now applies to his venture capital endeavors. He also gained valuable early experience at Hyde Park Angels, further solidifying his commitment to supporting emerging businesses.

Throughout his career at Sandbox Industries, Chris Zock has been involved with numerous impactful investments. While specific individual deal leads can be proprietary, his involvement with the BlueCross BlueShield Venture Fund and Healthbox places him at the forefront of investments in companies like Livongo (acquired by Teladoc Health), a leader in chronic condition management, and Solera Health, which connects patients with evidence-based health programs. These investments exemplify his commitment to backing companies that not only offer strong financial returns but also deliver significant societal value by improving health outcomes. Zock's strategic vision and hands-on approach continue to make him a key driver of innovation within the venture capital and healthcare technology ecosystems.